Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Dolby Laboratories stock | $91.35

Learn how to easily invest in Dolby Laboratories stock.

Dolby Laboratories Inc is an information technology services business based in the US. Dolby Laboratories shares (DLB) are listed on the NYSE and all prices are listed in US Dollars. Dolby Laboratories employs 2,289 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Dolby Laboratories

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DLB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Dolby Laboratories stock price (NYSE: DLB)

Use our graph to track the performance of DLB stocks over time.

Dolby Laboratories shares at a glance

Information last updated 2021-10-24.
Latest market close$91.35
52-week range$69.44 - $104.26
50-day moving average $91.37
200-day moving average $96.81
Wall St. target price$118.33
PE ratio 32.7182
Dividend yield $0.88 (0.95%)
Earnings per share (TTM) $2.81

Buy Dolby Laboratories shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Dolby Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dolby Laboratories price performance over time

Historical closes compared with the close of $91.35 from 2021-10-25

1 week (2021-10-20) -0.79%
1 month (2021-09-27) -0.40%
3 months (2021-07-27) -4.05%
6 months (2021-04-27) -10.00%
1 year (2020-10-26) 28.16%
2 years (2019-10-25) 42.94%
3 years (2018-10-26) 39.59%
5 years (2016-10-26) 83.14%

Is Dolby Laboratories under- or over-valued?

Valuing Dolby Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dolby Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Dolby Laboratories's P/E ratio

Dolby Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Dolby Laboratories shares trade at around 33x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Dolby Laboratories's PEG ratio

Dolby Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4752. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Dolby Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Dolby Laboratories's EBITDA

Dolby Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $428.8 million.

The EBITDA is a measure of a Dolby Laboratories's overall financial performance and is widely used to measure a its profitability.

Dolby Laboratories financials

Revenue TTM $1.3 billion
Operating margin TTM 26.12%
Gross profit TTM $1 billion
Return on assets TTM 6.85%
Return on equity TTM 11.87%
Profit margin 23.11%
Book value $25.87
Market capitalisation $9.3 billion

TTM: trailing 12 months

Shorting Dolby Laboratories shares

There are currently 618,332 Dolby Laboratories shares held short by investors – that's known as Dolby Laboratories's "short interest". This figure is 1.2% up from 610,955 last month.

There are a few different ways that this level of interest in shorting Dolby Laboratories shares can be evaluated.

Dolby Laboratories's "short interest ratio" (SIR)

Dolby Laboratories's "short interest ratio" (SIR) is the quantity of Dolby Laboratories shares currently shorted divided by the average quantity of Dolby Laboratories shares traded daily (recently around 330658.82352941). Dolby Laboratories's SIR currently stands at 1.87. In other words for every 100,000 Dolby Laboratories shares traded daily on the market, roughly 1870 shares are currently held short.

However Dolby Laboratories's short interest can also be evaluated against the total number of Dolby Laboratories shares, or, against the total number of tradable Dolby Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Dolby Laboratories's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Dolby Laboratories shares in existence, roughly 10 shares are currently held short) or 0.0096% of the tradable shares (for every 100,000 tradable Dolby Laboratories shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Dolby Laboratories.

Find out more about how you can short Dolby Laboratories stock.

Dolby Laboratories share dividends


Dividend payout ratio: 24.79% of net profits

Recently Dolby Laboratories has paid out, on average, around 24.79% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.96% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Dolby Laboratories shareholders could enjoy a 0.96% return on their shares, in the form of dividend payments. In Dolby Laboratories's case, that would currently equate to about $0.88 per share.

While Dolby Laboratories's payout ratio might seem low, this can signify that Dolby Laboratories is investing more in its future growth.

Dolby Laboratories's most recent dividend payout was on 18 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 August 2021 (the "ex-dividend date").

Dolby Laboratories share price volatility

Over the last 12 months, Dolby Laboratories's shares have ranged in value from as little as $69.4354 up to $104.2587. A popular way to gauge a stock's volatility is its "beta".

DLB.US volatility(beta: 1.01)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Dolby Laboratories's is 1.0063. This would suggest that Dolby Laboratories's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Dolby Laboratories overview

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications. ; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment.

Frequently asked questions

What percentage of Dolby Laboratories is owned by insiders or institutions?
Currently 2.097% of Dolby Laboratories shares are held by insiders and 95.266% by institutions.
How many people work for Dolby Laboratories?
Latest data suggests 2,289 work at Dolby Laboratories.
When does the fiscal year end for Dolby Laboratories?
Dolby Laboratories's fiscal year ends in September.
Where is Dolby Laboratories based?
Dolby Laboratories's address is: 1275 Market Street, San Francisco, CA, United States, 94103-1410
What is Dolby Laboratories's ISIN number?
Dolby Laboratories's international securities identification number is: US25659T1079
What is Dolby Laboratories's CUSIP number?
Dolby Laboratories's Committee on Uniform Securities Identification Procedures number is: 25659T107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site